SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH, et al. Lancet 2021;398:262-276.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH, et al. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet 2021;398:262-276.
PMID: 34216571